Hey guys, apologies for the formatting in the following. Playing monster trucks with my youngest, realised it may be of interest, so just pasting a text I sent to a mate yesterday:
My personal guess/take is that the announcement reeks of Pfizer. Specifically, the CRO. I'm drawing a bit of a long bow here, but a few points:
Firstly, I think (guessing) Parexel are too expensive for us.
Secondly, Parexel has had a decade long partnership with Pfizer: https://bit.ly/3mdNAEP
Finally, when Sarepta's DMD drug was approved, a Ronald Farkas quit the FDA quit and went to Parexel: https://bit.ly/3zY6yV1
i.e. If we were hoping to get into bed with Sarepta, this CRO would be an interesting choice.
Also worth looking at their experience in running trials across the US/EU. I'm excited!
Where others have failed will Atl1102 succeed ?, page-454
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.002(2.22%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.9¢ | 9.2¢ | 8.8¢ | $69.71K | 769.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35742 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.2¢ | 84100 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.2¢ |
Change
0.002 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| 8.9¢ | 9.2¢ | 8.8¢ | 138646 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PER (ASX) Chart |